Gqg Partners LLC Vertex Pharmaceuticals Inc Transaction History

Gqg Partners LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$207.01 - $276.09 $287 Million - $383 Million	-1,387,263 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$255.65 - $303.1 $57.4 Million - $68 Million	224,459 Added 19.3%	1,387,263 $377 Million
Q2 2020 Aug 14, 2020	BUY	$225.48 - $295.8 $100 Million - $132 Million	445,157 Added 62.03%	1,162,804 $338 Million
Q1 2020 May 14, 2020	BUY	$199.77 - $247.81 $126 Million - $156 Million	630,909 Added 727.37%	717,647 $171 Million
Q4 2019 Feb 13, 2020	BUY	$166.71 - $223.91 $13.2 Million - $17.7 Million	78,933 Added 1011.31%	86,738 $19 Million
Q3 2019 Nov 14, 2019	SELL	$166.23 - $187.09 $67.3 Million - $75.8 Million	-405,059 Reduced 98.11%	7,805 $1.32 Million
Q2 2019 Aug 14, 2019	SELL	$164.61 - $190.37 $16.8 Million - $19.4 Million	-101,995 Reduced 19.81%	412,864 $75.6 Million
Q1 2019 May 14, 2019	BUY	$163.73 - $194.7 $84.3 Million - $100 Million	514,859 New	514,859 $94.4 Million

1,716

225M

1.19M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Gqg Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Gqg Partners LLC with notifications on news.